138 related articles for article (PubMed ID: 21519125)
21. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.
Mitterreiter JG; Titulaer MJ; van Nierop GP; van Kampen JJ; Aron GI; Osterhaus AD; Verjans GM; Ouwendijk WJ
PLoS One; 2016; 11(5):e0155531. PubMed ID: 27171421
[TBL] [Abstract][Full Text] [Related]
23. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
Wang K; Mahalingam G; Hoover SE; Mont EK; Holland SM; Cohen JI; Straus SE
J Virol; 2007 Jul; 81(13):6817-26. PubMed ID: 17459924
[TBL] [Abstract][Full Text] [Related]
24. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
[TBL] [Abstract][Full Text] [Related]
25. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
[TBL] [Abstract][Full Text] [Related]
26. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
27. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients.
Morfin F; Souillet G; Bilger K; Ooka T; Aymard M; Thouvenot D
J Infect Dis; 2000 Jul; 182(1):290-3. PubMed ID: 10882609
[TBL] [Abstract][Full Text] [Related]
28. Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus.
Bohn K; Zell R; Schacke M; Wutzler P; Sauerbrei A
Antivir Ther; 2011; 16(7):989-97. PubMed ID: 22024514
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
30. Recurrent aciclovir-resistant herpes simplex in a child with Wiskott-Aldrich syndrome.
Saijo M; Suzutani T; Murono K; Hirano Y; Itoh K
Br J Dermatol; 1998 Aug; 139(2):311-4. PubMed ID: 9767251
[TBL] [Abstract][Full Text] [Related]
31. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
32. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.
Duan R; de Vries RD; van Dun JM; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2009 Nov; 200(9):1402-14. PubMed ID: 19795980
[TBL] [Abstract][Full Text] [Related]
33. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
[TBL] [Abstract][Full Text] [Related]
34. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
35. A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.
Valyi-Nagy T; Gesser RM; Raengsakulrach B; Deshmane SL; Randazzo BP; Dillner AJ; Fraser NW
Virology; 1994 Mar; 199(2):484-90. PubMed ID: 8122378
[TBL] [Abstract][Full Text] [Related]
36. Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance.
Schmidt S; Bohn-Wippert K; Schlattmann P; Zell R; Sauerbrei A
Antimicrob Agents Chemother; 2015 Aug; 59(8):4938-45. PubMed ID: 26055375
[TBL] [Abstract][Full Text] [Related]
37. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic and genotypic characterization of induced acyclovir-resistant clinical isolates of herpes simplex virus type 1.
Hussin A; Md Nor NS; Ibrahim N
Antiviral Res; 2013 Nov; 100(2):306-13. PubMed ID: 24055837
[TBL] [Abstract][Full Text] [Related]
39. Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir.
Sarisky RT; Cano R; Nguyen TT; Wittrock RJ; Duffy KE; Clark P; Bartus JO; Bacon TH; Caspers-Velu L; Hodinka RL; Leary JJ
Clin Infect Dis; 2001 Dec; 33(12):2034-9. PubMed ID: 11712095
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of herpes simplex virus reactivation by dipyridamole in a mouse model.
Hay KA; Gaydos A; Tenser RB
J Med Virol; 1996 Oct; 50(2):198-203. PubMed ID: 8915888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
